 NeuroSystec Corporation,
founded in April 2004, is combining modern drug delivery device
technologies with potent neurologically active therapeutics to treat
diseases of the nervous system, beginning with hearing-related
disorders. The company will combine the power of tissue-specific
drug delivery from partially or completely implantable drug delivery
devices with potent neurologically active therapeutics. This targeted,
local delivery will allow for treatment with effective
concentrations of therapeutics while minimizing the risk of side
effects associated with systemic delivery. Our initial program
focuses on tinnitus, a disorder of the inner ear.
NeuroSystec
Corporation, located in the Mann Biomedical Park in Valencia,
California, is in the beautiful Santa Clarita Valley just north of Los
Angeles and the San Fernando Valley. The park is also the
home to the Alfred E. Mann Foundation, a medical research foundation
dedicated to pioneering treatments for diabetes, addressing neural
muscular disorders, and restoring hearing. Mann Biomedical Park
and the surrounding areas are increasingly becoming the hub of
breakthrough device and pharmaceutical research activities.
A number of companies, all founded by the very successful entrepreneur
Alfred E. Mann, in the area include: Pacesetter, MiniMed,
Advanced Bionics, Quallion, Second Sight, Bioness, and MannKind
Corporation.
Our
management team has more than 60 years of combined experience in
the fields of medical devices, neurological research, neuro-active
chemical compounds, and associated therapies. CLICK
HERE to learn more about NeuroSystec, our Board of Directors and
management team and our development programs.
|
